Familial chylomicronaemia syndrome (FCS) is a rare autosomal recessive disorder, resulting in elevated triglycerides (TGs), abdominal pain and pancreatitis. Treatment options are limited. Lomitapide, a microsomal triglyceride transfer protein inhibitor, is approved for the treatment of homozygous familial hypercholesterolaemia. Whether its therapeutic use may be extended to FCS remains unknown. The aim of this study was to evaluate the efficacy and safety of lomitapide in adult patients with FCS.

Efficacy and safety of lomitapide in familial chylomicronaemia syndrome / Cefalù, Angelo B; D'Erasmo, Laura; Noto, Davide; Giammanco, Antonina; Montali, Anna; Zambon, Alberto; Forte, Francesco; Suppressa, Patrizia; Giannini, Stefano; Barbagallo, Carlo M; Ganci, Antonina; Nardi, Emilio; Vernuccio, Federica; Caldarella, Rosalia; Ciaccio, Marcello; Arca, Marcello; Averna, Maurizio; Iannuzzo, Gabriella. - In: ATHEROSCLEROSIS. - ISSN 1879-1484. - 359:(2022), pp. 13-19. [10.1016/j.atherosclerosis.2022.08.017]

Efficacy and safety of lomitapide in familial chylomicronaemia syndrome

Ciaccio, Marcello;Arca, Marcello;Averna, Maurizio;Iannuzzo, Gabriella
2022

Abstract

Familial chylomicronaemia syndrome (FCS) is a rare autosomal recessive disorder, resulting in elevated triglycerides (TGs), abdominal pain and pancreatitis. Treatment options are limited. Lomitapide, a microsomal triglyceride transfer protein inhibitor, is approved for the treatment of homozygous familial hypercholesterolaemia. Whether its therapeutic use may be extended to FCS remains unknown. The aim of this study was to evaluate the efficacy and safety of lomitapide in adult patients with FCS.
2022
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome / Cefalù, Angelo B; D'Erasmo, Laura; Noto, Davide; Giammanco, Antonina; Montali, Anna; Zambon, Alberto; Forte, Francesco; Suppressa, Patrizia; Giannini, Stefano; Barbagallo, Carlo M; Ganci, Antonina; Nardi, Emilio; Vernuccio, Federica; Caldarella, Rosalia; Ciaccio, Marcello; Arca, Marcello; Averna, Maurizio; Iannuzzo, Gabriella. - In: ATHEROSCLEROSIS. - ISSN 1879-1484. - 359:(2022), pp. 13-19. [10.1016/j.atherosclerosis.2022.08.017]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/896178
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 3
social impact